Quarterly
Annual
| Unit: USD | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-05-31 | 2010-02-28 | 2009-11-30 | 2009-08-31 | 2009-05-31 | 2009-02-28 | 2008-11-30 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provider | 122,811,000 | 118,939,000 | 118,665,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payer & life sciences | 29,111,000 | 31,959,000 | 24,007,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total revenue | 151,922,000 | 150,898,000 | 142,672,000 | 391,699,000 | 369,272,000 | 373,714,000 | 368,352,000 | 277,734,000 | 402,030,000 | 406,223,000 | 416,713,000 | 450,984,000 | 444,184,000 | 444,460,000 | 432,049,000 | 188,180,000 | 522,279,000 | 525,577,000 | 513,926,000 | 517,334,000 | 449,442,000 | 426,091,000 | 413,475,000 | 425,436,000 | 392,384,000 | 386,521,000 | 345,558,000 | 345,647,000 | 354,476,000 | 351,718,000 | 334,552,000 | 340,903,000 | 345,389,000 | 351,296,000 | 340,285,000 | 350,977,000 | 330,191,000 | 344,827,000 | 347,066,000 | -482,053,000 | 360,694,000 | 369,956,000 | 364,712,000 | 383,175,000 | 368,763,000 | 356,831,000 | 335,308,000 | 242,393,000 | 190,328,000 | 179,919,000 | 169,344,000 | 164,910,000 | 166,334,000 | 160,703,000 | 128,613,000 | 81,804,000 | 81,512,000 | 72,089,000 | 73,401,000 | 73,444,000 | 70,041,000 | 65,022,000 | 63,560,000 | 62,191,000 | 60,014,000 | 42,204,000 | 34,197,000 | 30,638,000 | 29,534,000 | 26,195,000 | 26,313,000 | 25,694,000 | 25,608,000 | 23,155,000 | 23,653,000 | 22,488,000 |
yoy | -58.86% | -59.62% | -61.27% | 41.03% | -8.15% | -8.00% | -11.61% | -38.42% | -9.49% | -8.60% | -3.55% | 139.66% | -14.95% | -15.43% | -15.93% | -63.63% | 16.21% | 23.35% | 24.29% | 21.60% | 14.54% | 10.24% | 19.65% | 23.08% | 10.69% | 9.90% | 3.29% | 1.39% | 2.63% | 0.12% | -1.68% | -2.87% | 4.60% | 1.88% | -1.95% | -172.81% | -8.46% | -6.79% | -4.84% | -225.80% | -2.19% | 3.68% | 8.77% | 58.08% | 93.75% | 98.33% | 98.00% | 46.99% | 14.43% | 11.96% | 31.67% | 101.59% | 104.06% | 122.92% | 75.22% | 11.38% | 16.38% | 10.87% | 15.48% | 18.09% | 16.71% | 54.07% | 85.86% | 102.99% | 103.20% | 61.11% | 29.96% | 19.24% | 15.33% | 13.13% | 11.25% | 14.26% | ||||
qoq | 0.68% | 5.77% | -63.58% | 6.07% | -1.19% | 1.46% | 32.63% | -30.92% | -1.03% | -2.52% | -7.60% | 1.53% | -0.06% | 2.87% | 129.59% | -63.97% | -0.63% | 2.27% | -0.66% | 15.11% | 5.48% | 3.05% | -2.81% | 8.42% | 1.52% | 11.85% | -0.03% | -2.49% | 0.78% | 5.13% | -1.86% | -1.30% | -1.68% | 3.24% | -3.05% | 6.30% | -4.24% | -0.65% | -172.00% | -233.65% | -2.50% | 1.44% | -4.82% | 3.91% | 3.34% | 6.42% | 38.33% | 27.36% | 5.79% | 6.24% | 2.69% | -0.86% | 3.50% | 24.95% | 57.22% | 0.36% | 13.07% | -1.79% | -0.06% | 4.86% | 7.72% | 2.30% | 2.20% | 3.63% | 42.20% | 23.41% | 11.62% | 3.74% | 12.75% | -0.45% | 2.41% | 0.34% | 10.59% | -2.11% | 5.18% | |
cost of revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total cost of revenue | 68,486,000 | 71,416,000 | 69,191,000 | 222,706,000 | 220,498,000 | 221,961,000 | 218,307,000 | 195,081,000 | 240,433,000 | 241,739,000 | 259,752,000 | 270,923,000 | 268,882,000 | 260,338,000 | 257,954,000 | 115,646,000 | 303,908,000 | 312,914,000 | 292,951,000 | 303,235,000 | 247,523,000 | 238,600,000 | 234,823,000 | 239,138,000 | 226,225,000 | 219,837,000 | 193,660,000 | 191,844,000 | 201,128,000 | 208,094,000 | 204,762,000 | 204,549,000 | 213,933,000 | 211,308,000 | 202,099,000 | 212,778,000 | 204,644,000 | 208,545,000 | 212,638,000 | -310,019,000 | 203,658,000 | 212,466,000 | 209,035,000 | 212,255,000 | 201,763,000 | 189,036,000 | 175,458,000 | 117,981,000 | 87,772,000 | 78,245,000 | 73,794,000 | 75,840,000 | 74,221,000 | 77,422,000 | 61,851,000 | 41,433,000 | 40,362,000 | 36,048,000 | 37,528,000 | 36,648,000 | 34,570,000 | 32,749,000 | 29,575,000 | 31,635,000 | 28,742,000 | 22,079,000 | 18,630,000 | 17,378,000 | 15,653,000 | 14,028,000 | 13,977,000 | 14,617,000 | 15,519,000 | 14,009,000 | 14,341,000 | 13,833,000 |
gross profit | 83,436,000 | 79,482,000 | 73,481,000 | 168,993,000 | 148,774,000 | 151,753,000 | 150,045,000 | 82,653,000 | 161,597,000 | 164,484,000 | 156,961,000 | 180,061,000 | 175,302,000 | 184,122,000 | 174,095,000 | 72,534,000 | 218,371,000 | 212,663,000 | 220,975,000 | 214,099,000 | 201,919,000 | 187,491,000 | 178,652,000 | 186,298,000 | 166,159,000 | 166,684,000 | 151,898,000 | 153,803,000 | 153,348,000 | 143,624,000 | 129,790,000 | 136,354,000 | 131,456,000 | 139,988,000 | 138,186,000 | 138,199,000 | 125,547,000 | 136,282,000 | 134,428,000 | -172,034,000 | 157,036,000 | 157,490,000 | 155,677,000 | 170,920,000 | 167,000,000 | 167,795,000 | 159,850,000 | 124,412,000 | 102,556,000 | 101,674,000 | 95,550,000 | 89,070,000 | 92,113,000 | 83,281,000 | 66,762,000 | 40,371,000 | 41,150,000 | 36,041,000 | 35,873,000 | 36,796,000 | 35,471,000 | 32,273,000 | 33,985,000 | 30,556,000 | 31,272,000 | 20,125,000 | 15,567,000 | 13,260,000 | 13,881,000 | 12,167,000 | 12,336,000 | 11,077,000 | 10,089,000 | 9,146,000 | 9,312,000 | 8,655,000 |
yoy | -43.92% | -47.62% | -51.03% | 104.46% | -7.94% | -7.74% | -4.41% | -54.10% | -7.82% | -10.67% | -9.84% | 148.24% | -19.72% | -13.42% | -21.22% | -66.12% | 8.15% | 13.43% | 23.69% | 14.92% | 21.52% | 12.48% | 17.61% | 21.13% | 8.35% | 16.06% | 17.03% | 12.80% | 16.65% | 2.60% | -6.08% | -1.34% | 4.71% | 2.72% | 2.80% | -180.33% | -20.05% | -13.47% | -13.65% | -200.65% | -5.97% | -6.14% | -2.61% | 37.38% | 62.84% | 65.03% | 67.29% | 39.68% | 11.34% | 22.09% | 43.12% | 120.63% | 123.85% | 131.07% | 86.11% | 9.72% | 16.01% | 11.68% | 5.56% | 20.42% | 13.43% | 60.36% | 118.31% | 130.44% | 125.29% | 65.41% | 26.19% | 19.71% | 37.59% | 33.03% | 32.47% | 27.98% | ||||
qoq | 4.97% | 8.17% | -56.52% | 13.59% | -1.96% | 1.14% | 81.54% | -48.85% | -1.76% | 4.79% | -12.83% | 2.71% | -4.79% | 5.76% | 140.02% | -66.78% | 2.68% | -3.76% | 3.21% | 6.03% | 7.70% | 4.95% | -4.10% | 12.12% | -0.31% | 9.73% | -1.24% | 0.30% | 6.77% | 10.66% | -4.81% | 3.73% | -6.09% | 1.30% | -0.01% | 10.08% | -7.88% | 1.38% | -178.14% | -209.55% | -0.29% | 1.16% | -8.92% | 2.35% | -0.47% | 4.97% | 28.48% | 21.31% | 0.87% | 6.41% | 7.28% | -3.30% | 10.61% | 24.74% | 65.37% | -1.89% | 14.18% | 0.47% | -2.51% | 3.74% | 9.91% | -5.04% | 11.22% | -2.29% | 55.39% | 29.28% | 17.40% | -4.47% | 14.09% | -1.37% | 11.37% | 9.79% | 10.31% | -1.78% | 7.59% | |
gross margin % | 54.92% | 52.67% | 51.50% | 43.14% | 40.29% | 40.61% | 40.73% | 29.76% | 40.20% | 40.49% | 37.67% | 39.93% | 39.47% | 41.43% | 40.30% | 38.55% | 41.81% | 40.46% | 43.00% | 41.39% | 44.93% | 44.00% | 43.21% | 43.79% | 42.35% | 43.12% | 43.96% | 44.50% | 43.26% | 40.83% | 38.80% | 40.00% | 38.06% | 39.85% | 40.61% | 39.38% | 38.02% | 39.52% | 38.73% | 35.69% | 43.54% | 42.57% | 42.68% | 44.61% | 45.29% | 47.02% | 47.67% | 51.33% | 53.88% | 56.51% | 56.42% | 54.01% | 55.38% | 51.82% | 51.91% | 49.35% | 50.48% | 50.00% | 48.87% | 50.10% | 50.64% | 49.63% | 53.47% | 49.13% | 52.11% | 47.69% | 45.52% | 43.28% | 47.00% | 46.45% | 46.88% | 43.11% | 39.40% | 39.50% | 39.37% | 38.49% |
selling, general and administrative expenses | 32,518,000 | 59,847,000 | 41,318,000 | 74,222,000 | 78,794,000 | 79,090,000 | 81,708,000 | 80,802,000 | 97,231,000 | 114,620,000 | 97,288,000 | 112,835,000 | 101,152,000 | 105,542,000 | 100,245,000 | 25,602,000 | 133,214,000 | 149,081,000 | 143,070,000 | 146,037,000 | 117,352,000 | 112,037,000 | 110,845,000 | 115,132,000 | 98,778,000 | 94,802,000 | 84,153,000 | 79,354,000 | 91,043,000 | 86,749,000 | 82,029,000 | 85,038,000 | 97,034,000 | 86,663,000 | 89,946,000 | 109,273,000 | 104,506,000 | 104,402,000 | 104,232,000 | -47,232,000 | 90,412,000 | 92,291,000 | 97,317,000 | 87,771,000 | 94,120,000 | 101,532,000 | 104,148,000 | 103,826,000 | 61,745,000 | 54,672,000 | 55,622,000 | 52,959,000 | 55,181,000 | 47,709,000 | 64,113,000 | 32,605,000 | 32,850,000 | 31,393,000 | 26,694,000 | 27,173,000 | 25,425,000 | 22,374,000 | 25,361,000 | 21,330,000 | 22,706,000 | 16,401,000 | 11,464,000 | 10,025,000 | 11,458,000 | 10,357,000 | 10,337,000 | 9,453,000 | 9,103,000 | 8,760,000 | 9,084,000 | 9,618,000 |
research and development | 23,681,000 | 22,750,000 | 23,420,000 | 47,739,000 | 45,540,000 | 51,219,000 | 49,173,000 | 47,148,000 | 48,476,000 | 48,282,000 | 62,155,000 | 62,912,000 | 63,873,000 | 63,414,000 | 64,310,000 | 48,343,000 | 69,747,000 | 80,342,000 | 69,977,000 | 73,471,000 | 51,057,000 | 46,459,000 | 49,232,000 | 47,836,000 | 45,142,000 | 47,891,000 | 47,037,000 | 45,995,000 | 47,702,000 | 44,367,000 | 46,727,000 | 41,538,000 | 45,962,000 | 53,016,000 | 52,305,000 | 47,870,000 | 49,400,000 | 51,822,000 | 50,978,000 | -68,903,000 | 37,802,000 | 38,240,000 | 36,122,000 | 31,306,000 | 26,032,000 | 24,764,000 | 22,004,000 | 16,697,000 | 13,859,000 | 12,649,000 | 10,724,000 | 11,978,000 | 10,633,000 | 9,913,000 | 10,927,000 | |||||||||||||||||||||
asset impairment charges | 0 | 0 | 9,000 | 6,519,000 | 5,244,000 | 74,759,000 | 210,000 | 0 | 0 | 6,800,000 | 248,000 | 3,691,000 | 98,000 | 28,091,000 | 0 | 30,075,000 | 0 | 0 | 0 | 0 | 0 | 4,650,000 | 1,203,000 | 22,000 | 293,000 | 26,000 | 256,000 | 188,000 | 1,751,000 | 195,000 | 950,000 | 7,371,000 | -11,101,000 | 11,101,000 | ||||||||||||||||||||||||||||||||||||||||||
amortization of intangible and acquisition-related assets | 2,236,000 | 2,241,000 | 2,171,000 | 5,643,000 | 5,817,000 | 5,825,000 | 5,824,000 | 6,257,000 | 6,301,000 | 6,328,000 | 6,718,000 | 6,840,000 | 6,847,000 | 6,732,000 | 6,797,000 | -10,623,000 | 13,000,000 | 11,962,000 | 12,248,000 | 10,414,000 | 8,137,000 | 7,891,000 | 7,312,000 | 10,903,000 | 5,365,000 | 5,417,000 | 4,162,000 | 4,133,000 | 5,712,000 | 6,624,000 | 6,703,000 | 8,866,000 | 7,112,000 | 7,651,000 | 7,651,000 | 7,651,000 | 7,722,000 | 8,379,000 | ||||||||||||||||||||||||||||||||||||||
income from operations | 25,001,000 | -5,356,000 | 6,572,000 | 41,380,000 | 12,104,000 | 10,375,000 | 13,340,000 | -126,313,000 | 9,379,000 | -4,746,000 | -9,200,000 | -35,026,000 | 3,182,000 | 4,743,000 | 2,645,000 | -32,345,000 | 2,410,000 | -58,797,000 | -4,320,000 | -15,823,000 | 25,373,000 | 21,104,000 | 11,263,000 | 12,427,000 | 16,874,000 | 18,574,000 | 11,896,000 | 23,118,000 | 8,869,000 | 5,591,000 | -5,695,000 | 656,000 | -18,840,000 | -9,093,000 | -11,911,000 | -27,545,000 | -43,452,000 | -28,321,000 | -28,283,000 | -33,986,000 | 9,184,000 | 17,704,000 | 12,983,000 | 42,570,000 | 37,426,000 | 32,077,000 | 24,471,000 | -1,687,000 | 24,464,000 | 31,865,000 | 26,683,000 | 21,570,000 | 23,730,000 | 22,787,000 | 4,861,000 | 1,209,000 | 6,452,000 | 6,866,000 | 7,470,000 | 7,323,000 | 7,488,000 | 5,564,000 | 4,869,000 | 1,947,000 | 3,063,000 | 2,799,000 | 1,987,000 | 1,374,000 | 1,558,000 | 1,187,000 | 541,000 | -43,000 | ||||
yoy | 106.55% | -151.62% | -50.73% | -132.76% | 29.05% | -318.61% | -245.00% | 260.63% | 194.75% | -200.06% | -447.83% | 8.29% | 32.03% | -108.07% | -161.23% | 104.42% | -90.50% | -378.61% | -138.36% | -227.33% | 50.37% | 13.62% | -5.32% | -46.25% | 90.26% | 232.21% | -308.88% | 3424.09% | -147.08% | -161.49% | -52.19% | -102.38% | -56.64% | -67.89% | -57.89% | -18.95% | -573.13% | -259.97% | -317.85% | -179.84% | -75.46% | -44.81% | -46.95% | -2623.41% | 52.98% | 0.67% | -8.29% | -107.82% | 3.09% | 39.84% | 388.17% | 1784.78% | -34.93% | -83.49% | -13.84% | 23.40% | 53.42% | 276.12% | 144.47% | 98.79% | 145.04% | 41.70% | 96.60% | 135.80% | 267.28% | -3295.35% | ||||||||||
qoq | -566.78% | -181.50% | -84.12% | 241.87% | 16.67% | -22.23% | -110.56% | -1446.76% | -297.62% | -48.41% | -73.73% | -1200.75% | -32.91% | 79.32% | -108.18% | -1442.12% | -104.10% | 1261.04% | -72.70% | -162.36% | 20.23% | 87.37% | -9.37% | -26.35% | -9.15% | 56.14% | -48.54% | 160.66% | 58.63% | -198.17% | -968.14% | -103.48% | 107.19% | -23.66% | -56.76% | -36.61% | 53.43% | 0.13% | -16.78% | -470.06% | -48.12% | 36.36% | -69.50% | 13.74% | 16.68% | 31.08% | -1550.56% | -106.90% | -23.23% | 19.42% | 23.70% | -9.10% | 4.14% | 302.07% | -81.26% | -6.03% | -8.09% | 2.01% | -2.20% | 34.58% | 14.27% | 150.08% | -36.43% | 9.43% | 40.87% | 44.61% | -11.81% | 31.26% | 119.41% | -1358.14% | ||||||
operating margin % | 16.46% | -3.55% | 4.61% | 10.56% | 3.28% | 2.78% | 3.62% | -45.48% | 2.33% | -1.17% | -2.21% | -7.77% | 0.72% | 1.07% | 0.61% | -17.19% | 0.46% | -11.19% | -0.84% | -3.06% | 5.65% | 4.95% | 2.72% | 2.92% | 4.30% | 4.81% | 3.44% | 6.69% | 2.50% | 1.59% | -1.70% | 0.19% | -5.45% | -2.59% | -3.50% | -7.85% | -13.16% | -8.21% | -8.15% | 7.05% | 2.55% | 4.79% | 3.56% | 11.11% | 10.15% | 8.99% | 7.30% | -0.70% | 12.85% | 17.71% | 15.76% | 13.08% | 14.27% | 14.18% | 0% | 5.96% | 1.68% | 8.79% | 9.35% | 10.67% | 11.26% | 11.78% | 8.95% | 8.11% | 4.61% | 8.96% | 9.14% | 6.73% | 5.25% | 5.92% | 4.62% | 2.11% | -0.19% | 0% | ||
interest expense | -1,246,000 | -1,887,000 | -2,136,000 | -3,457,000 | -3,617,000 | -2,949,000 | -3,143,000 | -2,824,000 | -7,662,000 | -11,395,000 | -12,223,000 | -11,725,000 | -10,839,000 | -10,424,000 | -10,184,000 | 29,929,000 | -29,343,000 | -26,454,000 | -25,046,000 | -24,757,000 | -22,252,000 | -20,290,000 | -20,180,000 | -25,384,000 | -19,367,000 | -16,421,000 | -6,969,000 | -7,403,000 | -9,254,000 | -7,483,000 | -7,256,000 | -7,292,000 | -7,542,000 | -7,230,000 | -7,233,000 | -7,024,000 | -6,895,000 | -9,499,000 | -4,637,000 | 2,243,000 | -3,718,000 | -4,358,000 | -3,854,000 | -4,027,000 | -3,746,000 | -5,050,000 | -7,927,000 | -3,069,000 | -424,750 | -536,000 | -478,000 | -693,750 | -940,000 | -895,000 | -208,250 | -833,000 | ||||||||||||||||||||
other income | 1,655,000 | 2,133,000 | 12,000 | 65,172,000 | 4,700,000 | 16,757,000 | 1,037,000 | 9,000 | 398,000 | 522,000 | 4,798,000 | 781,000 | 513,000 | -19,000 | -917,000 | 958,000 | -570,000 | -214,000 | 239,000 | 621,000 | -6,000 | 106,000 | 366,000 | -98,000 | 423,000 | 148,000 | 1,886,000 | -1,000 | 171,000 | 230,000 | -32,000 | -213,000 | -826,000 | -33,500 | -8,000 | -118,000 | -5,000 | -48,000 | -65,000 | 93,000 | ||||||||||||||||||||||||||||||||||||
gain on sale of businesses | 0 | 7,000 | 8,363,000 | 0 | 0 | 0 | 173,129,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net income of unconsolidated investments | -617,000 | -207,000 | -398,000 | 2,078,000 | -257,000 | -86,000 | 22,000 | -223,000 | 383,000 | 16,834,000 | 200,000 | 125,000 | 386,000 | 218,000 | -64,000 | -270,000 | -177,000 | 767,000 | -61,000 | 115,000 | 449,000 | -28,000 | 285,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before income taxes | 24,793,000 | -5,317,000 | 4,050,000 | 105,180,000 | 21,293,000 | 24,097,000 | 11,256,000 | -20,701,000 | -43,524,000 | -6,490,000 | -150,457,000 | -6,045,000 | -2,022,000 | -27,635,000 | 78,639,000 | -35,844,000 | 2,895,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | -13,868,000 | 8,579,000 | 14,421,000 | -17,897,000 | -5,099,000 | -2,192,000 | -2,663,000 | 24,149,000 | -931,000 | -6,873,000 | 347,000 | 24,554,000 | 765,000 | 527,000 | -3,489,000 | 3,789,000 | -3,683,000 | 2,914,000 | 49,694,000 | 238,000 | 1,007,000 | 15,218,000 | 2,656,000 | 503,000 | -563,000 | 1,557,000 | -3,692,000 | 981,000 | 4,459,000 | 448,000 | -1,677,000 | -1,566,000 | 14,164,000 | 2,233,000 | ||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, net of tax | 10,925,000 | 3,262,000 | 18,471,000 | 87,283,000 | 16,194,000 | 21,905,000 | 8,593,000 | -18,970,000 | -5,725,000 | -149,930,000 | -7,977,000 | -5,511,000 | -23,846,000 | 74,956,000 | -32,930,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | -434,000 | -3,797,000 | -5,021,000 | -8,000 | -14,000 | 36,000 | -29,000 | 0 | 0 | 0 | 2,244,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of discontinued operations | 5,174,000 | 2,765,000 | 0 | 0 | 0 | 647,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax effect on discontinued operations | -1,137,000 | -66,256,000 | 9,407,000 | 0 | -15,000 | -154,000 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax | 3,603,000 | -67,288,000 | 4,386,000 | -8,000 | -14,000 | 21,000 | 464,000 | 0 | 0 | 0 | 391,407,000 | 0 | -684,000 | 4,415,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 14,528,000 | -64,026,000 | 22,857,000 | 87,275,000 | 16,180,000 | 21,926,000 | 9,057,000 | 727,824,000 | 542,000 | -7,605,000 | -20,354,000 | -18,970,000 | -5,725,000 | -149,930,000 | -7,977,000 | 385,896,000 | -23,846,000 | 74,272,000 | -28,515,000 | 14,863,000 | -17,462,000 | -143,011,000 | -8,565,000 | 2,882,000 | 157,000 | -2,136,000 | 2,127,000 | 16,377,000 | -5,133,000 | -3,216,000 | -10,084,000 | -2,178,000 | -25,763,000 | -17,770,000 | -20,742,000 | -20,618,000 | -48,940,000 | -22,876,000 | -11,592,000 | -28,734,000 | 9,375,000 | 7,981,000 | 5,813,000 | 24,136,000 | 20,984,000 | 15,876,000 | 12,613,000 | 1,373,000 | 15,689,000 | 18,470,000 | 15,779,000 | 12,932,000 | 13,361,000 | 13,250,000 | 4,016,000 | 2,352,000 | 80,000 | 5,944,000 | 4,124,000 | 6,028,000 | 4,467,000 | 4,483,000 | 3,262,000 | 2,827,000 | 1,323,000 | 3,403,000 | 2,940,000 | 2,033,000 | 1,334,000 | 1,403,000 | 742,000 | 696,000 | 267,000 | 116,000 | -918,000 | |
yoy | -10.21% | -392.01% | 152.37% | -88.01% | 2885.24% | -388.31% | -144.50% | -3936.71% | -109.47% | -94.93% | 155.16% | -104.92% | -75.99% | -301.87% | -72.03% | 2496.35% | 36.56% | -151.93% | 232.92% | 415.72% | -11222.29% | 6595.27% | -502.68% | -82.40% | -103.06% | -33.58% | -121.09% | -851.93% | -80.08% | -81.90% | -51.38% | -89.44% | -47.36% | -22.32% | 78.93% | -28.25% | -622.03% | -386.63% | -299.42% | -219.05% | -55.32% | -49.73% | -53.91% | 1657.90% | 33.75% | -14.04% | -20.06% | -89.38% | 17.42% | 39.40% | 222.01% | 468.07% | 16462.50% | -2.62% | -60.98% | -98.21% | 32.59% | 26.43% | 113.23% | 237.64% | 31.74% | 10.95% | 39.06% | -0.82% | 142.55% | 296.23% | 192.10% | 399.63% | 1109.48% | -180.83% | ||||||
qoq | -122.69% | -380.12% | -73.81% | 439.40% | -26.21% | 142.09% | -98.76% | 134184.87% | -107.13% | -62.64% | 7.30% | 231.35% | -96.18% | 1779.53% | -102.07% | -1718.28% | -132.11% | -360.47% | -291.85% | -185.12% | -87.79% | 1569.71% | -397.19% | 1735.67% | -107.35% | -200.42% | -87.01% | -419.05% | 59.61% | -68.11% | 362.99% | -91.55% | 44.98% | -14.33% | 0.60% | -57.87% | 113.94% | 97.34% | -59.66% | -406.50% | 17.47% | 37.30% | -75.92% | 15.02% | 32.17% | 25.87% | 818.65% | -91.25% | -15.06% | 17.05% | 22.02% | -3.21% | 0.84% | 70.75% | 2840.00% | -98.65% | 44.13% | -31.59% | 34.95% | -0.36% | 37.43% | 15.39% | 113.68% | -61.12% | 15.75% | 44.61% | 52.40% | -4.92% | 89.08% | 6.61% | 160.67% | 130.17% | -112.64% | |||
net income margin % | 9.56% | -42.43% | 16.02% | 22.28% | 4.38% | 5.87% | 2.46% | 262.06% | 0.13% | -1.87% | -4.88% | -4.21% | -1.29% | -33.73% | -1.85% | 205.07% | -4.57% | 14.13% | -5.55% | 2.87% | -3.89% | -33.56% | -2.07% | 0.68% | 0.04% | -0.55% | 0.62% | 4.74% | -1.45% | -0.91% | -3.01% | -0.64% | -7.46% | -5.06% | -6.10% | -5.87% | -14.82% | -6.63% | -3.34% | 5.96% | 2.60% | 2.16% | 1.59% | 6.30% | 5.69% | 4.45% | 3.76% | 0.57% | 8.24% | 10.27% | 9.32% | 7.84% | 8.03% | 8.25% | 4.91% | 2.89% | 0.11% | 8.10% | 5.62% | 8.61% | 6.87% | 7.05% | 5.25% | 4.71% | 3.13% | 9.95% | 9.60% | 6.88% | 5.09% | 5.33% | 2.89% | 2.72% | 1.15% | 0.49% | -4.08% | |
net income per share | 0.13 | -0.56 | 0.2 | 0.088 | 0.13 | 0.16 | 0.06 | 0.09 | 0.1 | 0.09 | 0.03 | 0.04 | 0 | 0.11 | 0.07 | 0.11 | 0.08 | 0.08 | 0.06 | 0.05 | 0.03 | 0.08 | 0.07 | 0.05 | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | -0.02 | ||||||||||||||||||||||||||||||||||||||||||||||
basic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | 0.1 | 0.03 | 0.16 | 0.68 | 0.13 | 0.16 | 0.06 | -0.13 | -0.03 | -0.9 | -0.04 | 0.19 | -0.2 | 0.36 | -0.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | 0.03 | -0.59 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 1.94 | 0 | 0 | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
software delivery, support and maintenance | 245,346,000 | 222,726,000 | 219,610,000 | 222,691,000 | 144,482,000 | 250,547,000 | 256,021,000 | 263,612,000 | 281,578,000 | 284,373,000 | 285,023,000 | 275,512,000 | 131,694,000 | 330,397,000 | 336,406,000 | 329,766,000 | 328,771,000 | 294,221,000 | 279,272,000 | 272,458,000 | 280,631,000 | 252,692,000 | 249,871,000 | 229,158,000 | 227,647,000 | 230,754,000 | 232,470,000 | 227,559,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
client services | 146,353,000 | 146,546,000 | 154,104,000 | 145,661,000 | 133,252,000 | 151,483,000 | 150,202,000 | 153,101,000 | 169,406,000 | 159,811,000 | 159,437,000 | 156,537,000 | 56,486,000 | 191,882,000 | 189,171,000 | 184,160,000 | 188,563,000 | 155,221,000 | 146,819,000 | 141,017,000 | 144,805,000 | 139,692,000 | 136,650,000 | 116,400,000 | 118,000,000 | 123,722,000 | 119,248,000 | 106,993,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
amortization of software development and acquisition-related assets | 29,256,000 | 29,894,000 | 30,061,000 | 29,489,000 | 22,539,000 | 33,207,000 | 32,012,000 | 30,641,000 | 29,493,000 | 29,295,000 | 29,030,000 | 28,222,000 | 1,868,000 | 34,557,000 | 32,678,000 | 33,773,000 | 32,813,000 | 28,001,000 | 27,300,000 | 26,487,000 | 25,726,000 | 23,273,000 | 22,000,000 | 17,632,000 | 18,980,000 | 21,347,000 | 20,743,000 | 20,916,000 | 19,690,000 | 20,582,000 | 19,912,000 | 21,031,000 | 22,665,000 | 23,006,000 | ||||||||||||||||||||||||||||||||||||||||||
impairment of long-term investments | 0 | 0 | 0 | -9,987,000 | -144,590,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(impairment) recovery of long-term investments | -393,750 | -1,025,000 | -550,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | -129,351,000 | 1,473,000 | -732,000 | -42,527,750 | -17,700,000 | -144,018,000 | -8,393,000 | -12,336,000 | -2,499,000 | -2,639,000 | 2,690,000 | 14,820,000 | -1,441,000 | -1,744,000 | -11,065,000 | -6,637,000 | -26,211,000 | -16,093,000 | -19,176,000 | -34,782,000 | -51,173,000 | -37,602,000 | -24,789,000 | -15,597,000 | -10,379,000 | 13,496,000 | 9,521,000 | 39,044,000 | 34,105,000 | 27,382,000 | 16,948,000 | -4,506,000 | 24,813,000 | 31,416,000 | 26,320,000 | 20,986,000 | 23,468,000 | 21,918,000 | 3,855,000 | 6,084,500 | 6,873,000 | 10,038,000 | 7,427,000 | 2,991,500 | 5,273,000 | 4,560,000 | 2,133,000 | 1,576,750 | 2,940,000 | 2,033,000 | 1,334,000 | 426,250 | 742,000 | 696,000 | 267,000 | |||||||||||||||||||||
net income attributable to non-controlling interests | 0 | 0 | 0 | 0 | 0 | 424,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to allscripts healthcare solutions, inc. stockholders | 727,824,000 | 542,000 | -7,605,000 | -20,354,000 | -18,970,000 | -5,725,000 | -149,930,000 | -7,553,000 | 374,781,000 | -35,991,000 | 64,824,000 | -39,874,000 | 5,818,000 | -28,587,000 | -153,710,000 | -19,980,000 | -7,314,000 | -10,185,000 | -10,202,000 | 2,049,000 | 16,327,000 | -5,244,000 | -3,225,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to allscripts healthcare solutions, inc. stockholders per share - basic | -0.043 | 0 | -0.05 | -0.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to allscripts healthcare solutions, inc. stockholders per share - diluted | -0.043 | 0 | -0.05 | -0.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other loss | -875,000 | -144,994,000 | -147,500 | -525,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
recovery of long-term investments | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
recovery (impairment) of long-term investments | 261,250 | 0 | 1,045,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accretion of redemption preference on redeemable convertible non-controlling interest - discontinued operations | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to allscripts healthcare solutions, inc. stockholders per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | 0.03 | -0.59 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 1.94 | 0 | 0 | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to allscripts healthcare solutions, inc. stockholders per share | -0.13 | -0.03 | -0.9 | -0.04 | 2.13 | -0.2 | 0.36 | -0.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of businesses | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax provision | -1,932,000 | -172,000 | -1,472,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income (income) attributable to non-controlling interests | 1,033,000 | 4,000 | 2,700,000 | 790,000 | 264,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: accretion of redemption preference on redeemable convertible non-controlling interest - netsmart | -9,111,500 | -12,149,000 | -12,148,000 | -12,149,000 | -10,963,000 | -10,962,000 | -10,963,000 | -10,962,000 | -10,192,000 | -10,191,000 | -8,153,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of and losses on long-term investments | -5,500,000 | -20,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to non-controlling interests | -88,000 | -163,000 | -453,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share - basic attributable to allscripts healthcare solutions, inc. stockholders | -0.28 | -0.16 | -0.85 | -0.04 | -0.06 | -0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share - diluted attributable to allscripts healthcare solutions, inc. stockholders | -0.28 | -0.16 | -0.85 | -0.04 | -0.06 | -0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share - basic attributable to allscripts healthcare solutions, inc. stockholders | -0.11 | 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share - diluted attributable to allscripts healthcare solutions, inc. stockholders | -0.11 | 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to non-controlling interest | -35,500 | -151,000 | -78,000 | -50,000 | -111,000 | -9,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net earnings of unconsolidated investments | -4,898,000 | -2,603,000 | -797,000 | -1,479,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income (income) attributable to non-controlling interest | 87,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share - basic and diluted attributable to allscripts healthcare solutions, inc. stockholders | 0.09 | -0.03 | -0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share - basic and diluted | -0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
system sales | 21,640,000 | 21,440,000 | 25,772,000 | 23,389,000 | 27,595,000 | 26,498,000 | 32,449,000 | 27,031,000 | -12,303,000 | 35,220,000 | 46,565,000 | 40,708,000 | 60,939,000 | 62,568,000 | 64,866,000 | 54,496,000 | 46,913,000 | 43,459,000 | 44,116,000 | 33,565,000 | 33,457,000 | 37,303,000 | 27,375,000 | 20,761,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
professional services | 50,477,000 | 54,825,000 | 62,374,000 | 50,364,000 | 61,231,000 | 49,003,000 | 59,206,000 | 61,084,000 | -107,740,000 | 62,749,000 | 67,380,000 | 71,486,000 | 71,344,000 | 65,275,000 | 58,134,000 | 55,595,000 | 38,948,000 | 23,748,000 | 17,433,000 | 18,340,000 | 15,918,000 | 16,711,000 | 15,928,000 | 11,782,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
maintenance | 117,991,000 | 117,454,000 | 113,580,000 | 117,077,000 | 120,109,000 | 117,928,000 | 116,204,000 | 117,708,000 | -153,549,000 | 119,263,000 | 113,899,000 | 114,816,000 | 110,104,000 | 110,349,000 | 103,249,000 | 100,334,000 | 76,827,000 | 65,660,000 | 62,117,000 | 61,305,000 | 59,419,000 | 56,697,000 | 56,099,000 | 46,734,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
transaction processing and other | 150,795,000 | 151,670,000 | 149,570,000 | 149,455,000 | 142,042,000 | 136,762,000 | 136,968,000 | 141,243,000 | -208,461,000 | 143,462,000 | 142,112,000 | 137,702,000 | 140,788,000 | 130,571,000 | 130,582,000 | 124,883,000 | 79,705,000 | 57,461,000 | 56,253,000 | 56,134,000 | 56,116,000 | 54,356,000 | 52,847,000 | 44,636,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share—basic and diluted | -0.09 | -0.15 | -0.09 | -0.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share—basic and diluted | -0.12 | -0.27 | -0.13 | -0.07 | -0.16 | 0.05 | 0.04 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of software development costs and acquisition-related costs | 19,991,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income and other | 218,000 | 8,131,000 | 150,000 | 392,000 | 501,000 | 425,000 | 355,000 | 404,000 | 250,000 | 643,000 | 87,000 | 115,000 | 101,000 | 250,000 | 91,000 | 284,000 | 128,000 | 377,000 | 769,250 | 934,000 | 1,106,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit for income taxes | 14,726,000 | 13,197,000 | -13,137,000 | 19,754,000 | -7,240,500 | -13,121,000 | 5,879,000 | -10,541,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of software development costs and acquisition-related assets | 19,539,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of intangible assets | 7,501,000 | -10,812,000 | 8,537,000 | 9,255,000 | 9,255,000 | 9,273,000 | 9,422,000 | 9,422,000 | 9,227,000 | 5,576,000 | 2,488,000 | 2,488,000 | 2,521,000 | 2,563,000 | 2,569,000 | 2,872,000 | 1,256,000 | 3,439,000 | 3,439,000 | 1,977,250 | 2,757,000 | 2,576,000 | 2,576,000 | 1,924,000 | 3,045,000 | 3,281,000 | 1,370,000 | 327,000 | 436,000 | 436,000 | 436,000 | 327,750 | 437,000 | 445,000 | 429,000 | 140,750 | 295,000 | |||||||||||||||||||||||||||||||||||||||
interest income and other (expense) | 16,146,000 | -15,845,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income taxes | -5,515,000 | -3,708,000 | -11,506,000 | -4,335,000 | -7,885,500 | -12,946,000 | 2,067,250 | 8,668,000 | 1,123,000 | 1,503,000 | 2,429,750 | 2,749,000 | 4,010,000 | 2,960,000 | 1,138,500 | 2,011,000 | 1,733,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share - basic and diluted | 0.065 | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.08 | 0.07 | 0.01 | 0.08 | 0.12 | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 0.08 | 0.06 | 0.01 | 0.078 | 0.12 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total software and related services | 242,393,000 | 190,328,000 | 179,919,000 | 169,344,000 | 123,913,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepackaged medications | 0 | 0 | 1,267,000 | 8,454,000 | 4,700,000 | 9,991,000 | 9,493,000 | 9,595,000 | 11,887,000 | 10,904,000 | 10,939,000 | 10,229,000 | 11,232,000 | 10,438,000 | 10,508,000 | 11,510,000 | 12,789,000 | 11,496,000 | 11,489,000 | 9,835,000 | 9,342,000 | 11,811,000 | 12,396,000 | 11,184,000 | 11,894,000 | 10,990,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 148,754 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 150,560 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | 0.13 | -0.56 | 0.2 | 0.088 | 0.13 | 0.16 | 0.06 | 0.09 | 0.1 | 0.09 | 0.03 | 0.04 | 0 | 0.11 | 0.07 | 0.11 | 0.08 | 0.08 | 0.06 | 0.05 | 0.03 | 0.08 | 0.07 | 0.05 | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | -0.02 | ||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares of common stock outstanding used in computing basic net income per share | 146,357 | 122,591 | 146,121 | 118,912 | 57,008 | 56,766 | 56,191 | 55,648 | 54,639 | 53,048 | 52,202 | 44,903 | 40,895 | 39,824 | 39,073 | 38,803 | 39,469 | 39,169 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares of common stock outstanding used in computing diluted net income per share | 149,963 | 127,628 | 151,081 | 118,912 | 58,201 | 57,772 | 65,225 | 64,802 | 64,462 | 55,676 | 55,282 | 47,974 | 44,223 | 43,144 | 42,171 | 41,164 | 42,431 | 41,869 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total software and services revenue | 165,067,000 | 152,249,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total software and services cost of revenue | 73,261,000 | 70,756,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations before income taxes | 130,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
software and related services | 71,813,000 | 68,179,000 | 58,618,000 | 57,767,000 | 58,985,000 | 54,681,000 | 51,240,000 | 48,910,000 | 49,534,000 | 46,745,000 | 28,314,000 | 18,249,000 | 16,462,000 | 16,145,000 | 14,310,000 | 14,306,000 | 10,986,000 | 9,934,000 | 8,895,000 | 8,318,000 | 8,232,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 4,327,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of equity investment | 2,392,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations | 1,772,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from discontinued operations | 2,244,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
information services | 3,840,000 | 3,876,000 | 3,747,000 | 3,555,000 | 4,421,000 | 3,553,000 | 3,418,000 | 2,219,000 | 2,761,000 | 2,380,000 | 3,159,000 | 2,680,000 | 1,900,000 | 2,050,000 | 2,665,000 | 2,897,000 | 3,278,000 | 3,076,000 | 3,441,000 | 3,266,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of intangibles | 3,439,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income | 570,000 | 1,049,000 | 813,000 | 657,000 | 639,000 | 1,199,000 | 1,230,000 | 1,064,000 | 957,000 | 877,000 | 802,000 | 436,000 | 220,000 | 217,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income tax | 50,000 | 810,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding used in computing basic net income per share | 56,503 | 55,712 | 51,058 | 40,045 | 38,979 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding used in computing diluted net income per share | 57,503 | 64,671 | 53,367 | 43,068 | 41,592 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation expense | 360,000 | 617,000 | 416,000 | 407,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restructuring and other charges | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other income | 270,500 | 340,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares of common stock outstanding used in computing net income per share—basic and diluted | 38,628 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.